Acadia Healthcare Company, Inc. (ACHC)
USD 23.31
(2.33%)
USD 23.31
(2.33%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.47 Billion USD | 18.41% |
| 2022 | 2.08 Billion USD | -4.5% |
| 2021 | 2.18 Billion USD | -52.49% |
| 2020 | 4.59 Billion USD | 5.17% |
| 2019 | 4.37 Billion USD | 13.92% |
| 2018 | 3.83 Billion USD | -0.32% |
| 2017 | 3.85 Billion USD | -0.14% |
| 2016 | 3.85 Billion USD | 48.56% |
| 2015 | 2.59 Billion USD | 93.37% |
| 2014 | 1.34 Billion USD | 80.47% |
| 2013 | 743.94 Million USD | 35.05% |
| 2012 | 550.86 Million USD | 73.98% |
| 2011 | 316.63 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.61 Billion USD | 2.82% |
| 2024 Q1 | 2.54 Billion USD | 2.86% |
| 2024 Q3 | 2.72 Billion USD | 4.25% |
| 2023 Q3 | 2.53 Billion USD | 18.59% |
| 2023 FY | 2.47 Billion USD | 18.41% |
| 2023 Q1 | 2.11 Billion USD | 1.31% |
| 2023 Q4 | 2.47 Billion USD | -2.56% |
| 2023 Q2 | 2.13 Billion USD | 1.15% |
| 2022 FY | 2.08 Billion USD | -4.5% |
| 2022 Q4 | 2.08 Billion USD | -1.15% |
| 2022 Q3 | 2.11 Billion USD | -1.54% |
| 2022 Q2 | 2.14 Billion USD | -2.09% |
| 2022 Q1 | 2.18 Billion USD | 0.21% |
| 2021 Q2 | 2.2 Billion USD | -0.96% |
| 2021 FY | 2.18 Billion USD | -52.49% |
| 2021 Q1 | 2.22 Billion USD | -51.54% |
| 2021 Q3 | 2.16 Billion USD | -2.14% |
| 2021 Q4 | 2.18 Billion USD | 1.15% |
| 2020 FY | 4.59 Billion USD | 5.17% |
| 2020 Q1 | 4.25 Billion USD | -2.74% |
| 2020 Q3 | 4.49 Billion USD | 3.89% |
| 2020 Q4 | 4.59 Billion USD | 2.25% |
| 2020 Q2 | 4.32 Billion USD | 1.79% |
| 2019 Q3 | 4.3 Billion USD | -1.39% |
| 2019 FY | 4.37 Billion USD | 13.92% |
| 2019 Q1 | 4.38 Billion USD | 14.14% |
| 2019 Q2 | 4.36 Billion USD | -0.32% |
| 2019 Q4 | 4.37 Billion USD | 1.54% |
| 2018 Q2 | 3.84 Billion USD | -0.86% |
| 2018 FY | 3.83 Billion USD | -0.32% |
| 2018 Q3 | 3.84 Billion USD | -0.01% |
| 2018 Q1 | 3.88 Billion USD | 0.82% |
| 2018 Q4 | 3.83 Billion USD | -0.26% |
| 2017 Q2 | 3.85 Billion USD | 0.56% |
| 2017 Q1 | 3.82 Billion USD | -0.7% |
| 2017 Q4 | 3.85 Billion USD | -0.09% |
| 2017 FY | 3.85 Billion USD | -0.14% |
| 2017 Q3 | 3.85 Billion USD | 0.1% |
| 2016 Q3 | 4.21 Billion USD | -0.88% |
| 2016 Q1 | 4.13 Billion USD | 59.21% |
| 2016 FY | 3.85 Billion USD | 48.56% |
| 2016 Q4 | 3.85 Billion USD | -8.4% |
| 2016 Q2 | 4.24 Billion USD | 2.78% |
| 2015 Q1 | 2.37 Billion USD | 77.07% |
| 2015 Q4 | 2.59 Billion USD | 4.91% |
| 2015 Q3 | 2.47 Billion USD | 9.5% |
| 2015 Q2 | 2.26 Billion USD | -4.93% |
| 2015 FY | 2.59 Billion USD | 93.37% |
| 2014 Q3 | 1.25 Billion USD | 79.81% |
| 2014 Q2 | 697.33 Million USD | -11.37% |
| 2014 Q1 | 786.79 Million USD | 5.76% |
| 2014 FY | 1.34 Billion USD | 80.47% |
| 2014 Q4 | 1.34 Billion USD | 7.08% |
| 2013 FY | 743.94 Million USD | 35.05% |
| 2013 Q2 | 663.33 Million USD | 2.32% |
| 2013 Q3 | 696.45 Million USD | 4.99% |
| 2013 Q4 | 743.94 Million USD | 6.82% |
| 2013 Q1 | 648.31 Million USD | 17.69% |
| 2012 Q4 | 550.86 Million USD | 57.3% |
| 2012 FY | 550.86 Million USD | 73.98% |
| 2012 Q3 | 350.19 Million USD | 2.97% |
| 2012 Q2 | 340.1 Million USD | -3.53% |
| 2012 Q1 | 352.57 Million USD | 11.35% |
| 2011 Q3 | 192.62 Million USD | 0.0% |
| 2011 Q4 | 316.63 Million USD | 64.38% |
| 2011 FY | 316.63 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Addus HomeCare Corporation | 317.73 Million USD | -677.756% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -1807.364% |
| Amedisys, Inc. | 940.38 Million USD | -162.783% |
| Astrana Health, Inc. | 522.59 Million USD | -372.869% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | -40.042% |
| IMAC Holdings, Inc. | 1.89 Million USD | -130183.915% |
| biote Corp. | 191.84 Million USD | -1188.14% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -3320.225% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -1100.045% |
| COMPASS Pathways plc | 50.24 Million USD | -4818.458% |
| DocGo Inc. | 185.28 Million USD | -1233.748% |
| The Ensign Group, Inc. | 2.68 Billion USD | 7.799% |
| Healthcare Services Group, Inc. | 346.56 Million USD | -613.048% |
| InnovAge Holding Corp. | 247.85 Million USD | -897.035% |
| The Joint Corp. | 62.37 Million USD | -3861.561% |
| LifeStance Health Group, Inc. | 804.27 Million USD | -207.255% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -64740.618% |
| ModivCare Inc. | 1.61 Billion USD | -53.387% |
| NewGenIvf Group Limited | 1.24 Million USD | -198958.428% |
| Option Care Health, Inc. | 1.9 Billion USD | -29.606% |
| P3 Health Partners Inc. | 427.3 Million USD | -478.318% |
| P3 Health Partners Inc. | 427.3 Million USD | -478.318% |
| The Pennant Group, Inc. | 394.17 Million USD | -526.923% |
| Surgery Partners, Inc. | 3.65 Billion USD | 32.43% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -271436.867% |
| Talkspace, Inc. | 23.57 Million USD | -10382.21% |
| Talkspace, Inc. | 23.57 Million USD | -10382.21% |
| The Oncology Institute, Inc. | 162.39 Million USD | -1421.729% |
| The Oncology Institute, Inc. | 162.39 Million USD | -1421.729% |